Rolf Dominicus

UNVERIFIED PROFILE

Are you Rolf Dominicus? Register this Author

Register author

Publications by authors named "Rolf Dominicus"

Are you Rolf Dominicus? Register this Author

3Publications

42Reads

Erratum to: Efficacy and Safety of 5-Fluorouracil 0.5%/Salicylic Acid 10% in the Field-Directed Treatment of Actinic Keratosis: A Phase III, Randomized, Double-Blind, Vehicle-Controlled Trial.

Authors:

Eggert Stockfleth Ralph von Kiedrowski Rolf Dominicus John Ryan Adam Ellery Meritxell Falqués Nathalie Ivanoff Rosario Rodriguez Azeredo

Dermatol Ther (Heidelb) 2017 Jun;7(2):263

Almirall S.A., Barcelona, Spain.

June 2017

Efficacy and Safety of 5-Fluorouracil 0.5%/Salicylic Acid 10% in the Field-Directed Treatment of Actinic Keratosis: A Phase III, Randomized, Double-Blind, Vehicle-Controlled Trial.

Authors:

Eggert Stockfleth Ralph von Kiedrowski Rolf Dominicus John Ryan Adam Ellery Meritxell Falqués Nathalie Ivanoff Rosario Rodriguez Azeredo

Dermatol Ther (Heidelb) 2017 Mar 19;7(1):81-96. Epub 2016 Dec 19.

Almirall S.A., Barcelona, Spain.

March 2017

Immunogenicity and safety of one dose of diphtheria, tetanus, acellular pertussis and poliomyelitis vaccine (Repevax®) followed by two doses of diphtheria, tetanus and poliomyelitis vaccine (Revaxis®) in adults aged ≥ 40 years not receiving a diphtheria- and tetanus-containing vaccination in the last 20 years.

Authors:

Rolf Dominicus Florence Galtier Patrick Richard Martine Baudin

Vaccine 2014 Jun 19;32(31):3942-9. Epub 2014 May 19.

Sanofi Pasteur MSD, 162, avenue Jean Jaurès, CS 50712, 69367 Lyon Cedex 07, France. Electronic address:

June 2014